World News Insights
1-3 Minute Gist

Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.

All Topics Articles

LyrArc brings in selected articles from many of the world's top publications.

Articles are selected by experts and you can see the gist of the important articles.

French pharma giant Sanofi to produce rivals’ Covid vaccines

  
The Times - 01.27.2021 Original article ›
Charles Bremner, Paris
LyrArc Article Gist
"Its a sign of the decline of the country, and this decline is unacceptable," says a key Macron ally, Francois Bayrou, who heads long term state planning. France lacks a vaccine developed by its scientists. France was a leader in vaccine technology and the world looked up to France for new medical breakthroughs. Something has gone wrong and this is causing soul searching in France and friendly countries. 

The Pasteur Institute was a leader in medical science. It has failed to develop a vaccine. Sanofi says it will be the end of the year 2021 when a vaccine is developed.

 

Read LyrArc gist ›
Original article 1 minute, gist 1 minute

Sanofi to Help Make Moderna Covid-19 Vaccine for U.S.

  
WSJ - 04.26.2021 Original article ›
Peter Loftus
LyrArc Article Gist
Sanofi will use its manufacturing plant in Ridgefield, New Jersey, in the US to fill vials and finish packaging of 200 million doses of Moderna vaccine, under a new agreement. This will supply the US under Moderna's US supply of vaccine agreements that run through April 2022. This is part of industry collaboration to expand supply of global vaccines, that includes Merck and Novartis.

Read LyrArc gist ›
Original article 3 minutes, gist 1 minute

GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine

  
The Guardian - 05.17.2021 Original article ›
LyrArc Article Gist
The French British collaboration effort will bring a new vaccine to the global effort against coronavirus. This vaccine was expected in February 21. It will be ready by the third quarter of 2021 just as vaccine supplies are being ramped up. The Sanofi Pasteur unit and GSK Glaxo SmithKline are the two companies in this vaccine venture. This vaccine will address the problem of new mutations of the virus in the British and South African versions and can be stored at normal temperatures. 
 

The new vaccines will boost supplies just when the situation is bleak for vaccine supplies in Latin America and Africa, South East Asia, places left out in the vaccine race in advanced countries and in India. Britain has ordered 60 million doses. 

Read LyrArc gist ›

Sanofi Names Olivier Brandicourt CEO

5 Groups   
Wall Street Journal - 02.20.2015 Original article ›
Noemi Bisserbe, Noemi, Bisserbe

Sanofi Dengue Vaccine Is Promising

3 Groups   
Wall Street Journal - 07.25.2012 Original article ›
Jeanne Whalen, Jeanne, Whalen

Sanofi Fires CEO as Tensions Boil Over

4 Groups   
Wall Street Journal - 10.30.2014 Original article ›
Noemie Bisserbe, Noemie, Bisserbe, Jeanne Whalen, Jeanne, Whalen, Hester Plumridge, Hester, Plumridge

Sanofi Makes Public a $18.5 Billion Bid for Genzyme

4 Groups   
New York Times - 08.29.2010 Original article ›
Andrew Ross Sorkin, Andrew, Ross, Sorkin, Duff Wilson, Duff, Wilson

Sanofi Fires Its Chief Executive but Retains His Global Strategy

5 Groups   
New York Times - 10.29.2014 Original article ›
David Jolly, David, Jolly, Andrew Pollack, Andrew, Pollack

Sanofi Buys TargeGen, Boosting Oncology Pipeline

3 Groups   
Wall Street Journal - 07.01.2010 Original article ›
Mimosa Spencer, Mimosa, Spencer

How a Sanofi Diabetes Bet Went Wrong

6 Groups   
Wall Street Journal - 02.10.2016 Original article ›
Denise Roland, Denise, Roland, Noemi Bisserbe, Noemi, Bisserbe

Sanofi Expands Diabetes Efforts With Licensing Deal

2 Groups   
Wall Street Journal - 04.09.2010 Original article ›
Mimosa Spencer, Mimosa, Spencer

FDA Approves Cholesterol Drug From Regeneron, Sanofi

6 Groups   
Wall Street Journal - 07.25.2015 Original article ›
Ron Winslow, Ron, Winslow
LyrArc Article Gist
Treatment costs with Praluent for cholesterol control are extremely high at $14,600 a year.
Read LyrArc gist ›

Sanofi to Join Regeneron in Quest to Unleash Immune System on Cancer

4 Groups   
New York Times - 07.28.2015 Original article ›
Andrew Pollack, Andrew, Pollack

Covid-19 Live Updates: Biden Vows to Speed Up the Pace of Inoculations

  
NYTimes.com - 01.27.2021 Original article ›
Sheryl Gay Stolberg, Noah Weiland, Sharon La Franiere
LyrArc Article Gist
French pharmaceutical company Sanofi will produce 100 million doses of the Pfizer vaccine to meet vaccine shortages in Europe. Sanofi's own vaccine will take longer, possibly till the end of 2021.

Read LyrArc gist ›

Coronavirus Vaccine Front-Runners Emerge, Rollouts Weighed

  
WSJ - 05.17.2020 Original article ›
Peter Loftus
LyrArc Article Gist
Moderna, J&J, Pfizer in the U.S., Sanofi in France, AstraZeneca in Britain, have accelerated their efforts to have a vaccine ready by the fall.  Moderna and Pfizer use new technologies. Astra Zeneca is working with Oxford University on a vaccine that builds on existing technologies. Both AstraZeneca and Sanofi are building capacity to make hundreds of millions of doses of the vaccine. 

Read LyrArc gist ›
Original article 5 minutes, gist 1 minute

Major Surgery at Sanofi

1 Groups   
BusinessWeek - 12.09.2009 Original article ›
Trista Kelley, Trista, Kelley, Albertena Torsoli, Albertena, Torsoli

Senate Panel Hits Sanofi Payments

1 Groups   
Wall Street Journal - 05.25.2011 Original article ›
Alicia Mundy, Alicia, Mundy

Bid for Genzyme by Sanofi Likely

1 Groups   
Wall Street Journal - 07.29.2010 Original article ›
Dana Cimilluca, Dana, Cimilluca, Gina Chon, Gina, Chon

Sanofi to Buy Stake in Alnylam

1 Groups   
Wall Street Journal - 01.14.2014 Original article ›
Noemi Bisserbe, Noemi, Bisserbe

Genzyme, Sanofi at Odds Over Threshold Price

1 Groups   
Wall Street Journal - 08.24.2010 Original article ›
Gina Chon, Gina, Chon, Anupreeta Das, Anupreeta, Das

Sanofi Agrees to Buy Genzyme for $20.1 Billion

1 Groups   
New York Times - 02.17.2011 Original article ›
Chris Nicholson, Chris, Nicholson

Sanofi Agrees to Buy Chattem in OTC Push

1 Groups   
Wall Street Journal - 12.22.2009 Original article ›
Mimosa Spencer, Mimosa, Spencer

Sanofi Taps Biotech Firm to Bolster Its Pipeline

1 Groups   
New York Times - 11.11.2009 Original article ›
Andrew Pollack, Andrew, Pollack

Drug Maker Sanofi-Aventis Buys Chattem for $1.9 Billion

1 Groups   
New York Times - 12.22.2009 Original article ›
Reuters

Sanofi, Merck Revive Venture

  
Wall Street Journal - 03.10.2010 Original article ›
Jeanne Whalen, Jeanne, Whalen, Jonathan D. Rockoff, Jonathan, D., Rockoff

Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1




Support LyrArc →


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us